{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T11:06:22Z","timestamp":1775041582061,"version":"3.50.1"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["K12HS023000"],"award-info":[{"award-number":["K12HS023000"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.genhosppsych.2018.05.007","type":"journal-article","created":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T22:09:50Z","timestamp":1526940590000},"page":"62-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Concurrent use of ketamine and monoamine oxidase inhibitors in the treatment of depression: A letter to the editor"],"prefix":"10.1016","volume":"54","author":[{"given":"R.B.","family":"Katz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Toprak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.T.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Sanacora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Ostroff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.genhosppsych.2018.05.007_bb0005","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/jamapsychiatry.2017.0080","article-title":"A consensus statement on the use of ketamine in the treatment of mood disorders","volume":"74","author":"Sanacora","year":"2017","journal-title":"JAMA Psychiat"},{"issue":"7","key":"10.1016\/j.genhosppsych.2018.05.007_bb0010","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1176\/appi.ajp.2017.17020239","article-title":"A survey of the clinical, off-label use of ketamine as a treatment for psychiatric disorders","volume":"174","author":"Wilkinson","year":"2017","journal-title":"Am J Psychiatry"},{"issue":"11","key":"10.1016\/j.genhosppsych.2018.05.007_bb0015","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/j.euroneuro.2015.07.021","article-title":"Combination of intravenous S-ketamine and oral tranylcypromine in treatment-resistant depression: a report of two cases","volume":"25","author":"Bartova","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"issue":"5","key":"10.1016\/j.genhosppsych.2018.05.007_bb0020","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/0952-8180(90)90078-H","article-title":"Ketamine induction and monoamine oxidase inhibitors","volume":"2","author":"Doyle","year":"1990","journal-title":"J Clin Anesth"},{"key":"10.1016\/j.genhosppsych.2018.05.007_bb0025","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.17m11731","article-title":"Acute and longer-term outcomes using ketamine as a clinical treatment at the Yale Psychiatric Hospital","author":"Wilkinson","year":"2018","journal-title":"J Clin Psychiatry"},{"issue":"8","key":"10.1016\/j.genhosppsych.2018.05.007_bb0030","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/da.22501","article-title":"Ketamine's mechanism of action: a path to rapid-acting antidepressants","volume":"33","author":"Abdallah","year":"2016","journal-title":"Depress Anxiety"},{"issue":"6","key":"10.1016\/j.genhosppsych.2018.05.007_bb0035","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1097\/00000542-199712000-00011","article-title":"Ketamine decreases intracranial pressure and electroencephalographic activity in traumatic brain injury patients during propofol sedation","volume":"87","author":"Alban\u00e8se","year":"1997","journal-title":"Anesthesiology"},{"key":"10.1016\/j.genhosppsych.2018.05.007_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2018.02.025","article-title":"Blood pressure safety of subanesthetic ketamine for depression: a report on 684 infusions","author":"Riva-Posse","year":"2018","journal-title":"J Affect Disord"},{"issue":"6 Suppl","key":"10.1016\/j.genhosppsych.2018.05.007_bb0045","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/S0952-8180(97)00119-0","article-title":"Adverse drug interactions in anesthesia","volume":"9","author":"Bovill","year":"1997","journal-title":"J Clin Anesth"},{"issue":"8","key":"10.1016\/j.genhosppsych.2018.05.007_bb0050","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.4088\/JCP.11m07607","article-title":"Antidepressive treatment with monoamine oxidase inhibitors and the occurrence of intraoperative hemodynamic events: a restrospective observational cohort study","volume":"73","author":"Van Haelst","year":"2012","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"10.1016\/j.genhosppsych.2018.05.007_bb0055","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/bja\/55.5.457","article-title":"Antidepressants do not increase the lethality of ketamine in mice","volume":"55","author":"Bruce","year":"1983","journal-title":"Br J Anaesth"},{"issue":"2","key":"10.1016\/j.genhosppsych.2018.05.007_bb0060","first-page":"471P","article-title":"Potentiation of the cardiovascular effects of some catecholamines by a monoamine oxidase inhibitor","volume":"43","author":"Cuthbert","year":"1971","journal-title":"Br J Pharmacol"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834318301269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834318301269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:49:55Z","timestamp":1759013395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834318301269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":12,"alternative-id":["S0163834318301269"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2018.05.007","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Concurrent use of ketamine and monoamine oxidase inhibitors in the treatment of depression: A letter to the editor","name":"articletitle","label":"Article Title"},{"value":"General Hospital Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2018.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}